Suehiro K, Tanaka K, Matsuura T, Funao T, Yamada T, Mori T, Tsuchiya M, Nishikawa K
Department of Anaesthesiology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Anaesth Intensive Care. 2014 Jul;42(4):487-94. doi: 10.1177/0310057X1404200410.
This study aimed to assess whether preoperative oxidative stress levels can predict postoperative complications in patients undergoing cardiac surgery. Ninety-five cardiac surgery patients received an assessment of preoperative oxidative stress by measurement of hydroperoxide values in blood via the d-Rom test. Area under the receiver operating characteristic curve and also multivariate logistic regression were used to evaluate the prognostic significance of preoperative hydroperoxide concentrations in predicting the occurrence of major organ morbidity and mortality (MOMM). MOMM included death, deep sternal infection, reoperation, stroke, renal failure requiring haemodialysis and prolonged ventilation (>48 hours). The ability of preoperative hydroperoxide concentrations to predict MOMM was not significantly different from that of the European system for cardiac operative risk evaluation (EuroSCORE) (area under the receiver operating characteristic curve 0.822 versus 0.821 respectively, P=0.983). The optimal threshold value of hydroperoxide concentration to differentiate between patients with and without MOMM was 450 UCarr (sensitivity, 87.0%; specificity, 81.9%). Duration of intensive care unit stay, mechanical ventilation time and hospital stay were significantly longer in patients with preoperative hydroperoxide concentrations ≥450 UCarr (H group) compared to those patients with preoperative hydroperoxide concentrations <450 UCarr (L group). An increase in preoperative hydroperoxide concentrations remained associated with an increased risk of MOMM (odds ratios: 1.01, 95% confidence interval: 1.00 to 1.03) and prolonged intensive care unit stay (odds ratio 1.01, 95% confidence interval: 1.00 to 1.02), after adjusting for age, gender and EuroSCORE. In conclusion, an increased hydroperoxide concentration before cardiac surgery is an independent risk factor for severe postoperative complications.
本研究旨在评估术前氧化应激水平能否预测心脏手术患者的术后并发症。95例心脏手术患者通过d - Rom试验测量血液中的氢过氧化物值,接受术前氧化应激评估。采用受试者工作特征曲线下面积以及多因素逻辑回归分析,评估术前氢过氧化物浓度在预测主要器官发病和死亡(MOMM)发生方面的预后意义。MOMM包括死亡、深部胸骨感染、再次手术、中风、需要血液透析的肾衰竭以及延长通气时间(>48小时)。术前氢过氧化物浓度预测MOMM的能力与欧洲心脏手术风险评估系统(EuroSCORE)无显著差异(受试者工作特征曲线下面积分别为0.822和0.821,P = 0.983)。区分有或无MOMM患者的氢过氧化物浓度最佳阈值为450 UCarr(敏感性为87.0%;特异性为81.9%)。与术前氢过氧化物浓度<450 UCarr的患者(L组)相比,术前氢过氧化物浓度≥450 UCarr的患者(H组)在重症监护病房的停留时间、机械通气时间和住院时间显著更长。在调整年龄、性别和EuroSCORE后,术前氢过氧化物浓度升高仍与MOMM风险增加(比值比:1.01,95%置信区间:1.00至1.03)以及重症监护病房停留时间延长(比值比1.01,95%置信区间:1.00至1.02)相关。总之,心脏手术前氢过氧化物浓度升高是严重术后并发症的独立危险因素。